Literature DB >> 16093781

Racial disparities in risk factors for thrombosis.

Haruka Itakura1.   

Abstract

PURPOSE OF REVIEW: Until recently, the paucity of characterization of the epidemiology of venous thromboembolism among non-Caucasians has contributed to the misconception that race or ethnicity does not modify disease presentation. This review will describe the previously poorly documented magnitude of venous thromboembolism disease burden among four racial cohorts, by defining disease incidence and associated morbidity/mortality from available literature data. RECENT
FINDINGS: Emerging data suggest that African-Americans possess the highest burden of venous thromboembolism, and Asians the lowest, compared with the Caucasian population. In both racial groups, however, the inheritable thrombophilic risk factors prevalent in Caucasians (factor V Leiden, Prothrombin G20210A) are distinctly rare. The presence of yet undetermined modifiers of disease, conferring susceptibility or resistance to venous thromboembolism among these racial groups, is suspected and requires further investigation.
SUMMARY: Racial disparity in thrombotic disorders exists in the divergent patterns of disease incidence among different racial/ethnic cohorts, yet the genetic determinants of disease and modifiers of risk remain obscure. Further research focused on delineating the underlying etiologies of venous thromboembolism across different racial/ethnic groups promises to be a productive and much needed area of exploration.

Entities:  

Mesh:

Year:  2005        PMID: 16093781     DOI: 10.1097/01.moh.0000167746.26145.53

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  5 in total

1.  Predictors of Deep Venous Thrombosis in Hospitalized Patients With Liver Cirrhosis in the US.

Authors:  Ahmad Abou Yassine; Mohammad Abureesh; Rachelle Hamadi; Loai Dahabra; Mohammad Alshami; Deeb Liliane
Journal:  Cureus       Date:  2022-03-24

Review 2.  The role of ethnicity, age and gender in venous thromboembolism.

Authors:  Martina Montagnana; Emmanuel J Favaloro; Massimo Franchini; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

3.  The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis.

Authors:  Shanshan Xie; Jingjing Chen; Gang Xiong; Juan Li; Jinjin Wan; Ye Liu; Ruilai Xu; Weifang Zhang
Journal:  Eur J Clin Pharmacol       Date:  2021-08-03       Impact factor: 2.953

4.  Racial disparities in cancer-associated thrombosis.

Authors:  Tatini Datta; Ann Brunson; Anjlee Mahajan; Theresa Keegan; Ted Wun
Journal:  Blood Adv       Date:  2022-05-24

5.  Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice.

Authors:  Joanna Rupa-Matysek; Katarzyna Brzeźniakiewicz-Janus; Lidia Gil; Zbigniew Krasiński; Mieczysław Komarnicki
Journal:  Cancer Med       Date:  2018-05-15       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.